Report projects continued decline in contrast agents, radiopharma

12/23/2012 | Business Wire

Decreased reimbursements and payer restrictions will hold down the growth of the U.S. contrast agent and radiopharmaceutical market, according to a report from Millennium Research Group. These factors, as well as competition, fueled a 15% market decline between 2010 and 2012. The trend is expected to continue through 2017, although it will be moderated by the expected increase in demand among the growing elderly population, according to the report.

View Full Article in:

Business Wire

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC